JACOBS LEVY EQUITY MANAGEMENT, INC

Position in MGTX — MeiraGTx Holdings plc

CIK 884414 FLORHAM PARK, NJ

Position in MGTX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$13,714,082

+$13,595,674 QoQ

Shares Held

1,015,106

+7324.2% QoQ

Ownership

1.06%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

#16

of 156 holders

Holding Since

Jun 2020

9 quarters on record

Voting authority Sole 84% Shared 0% None 16%

Healthcare · as of Jun 30, 2026

JACOBS LEVY EQUITY MANAGEMENT, INC holds $741,570,791 across 81 Biotechnology names. MGTX ranks #10 (1.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	256,503	$159,939,880
2	RARE	Ultragenyx Pharmaceutical Inc.	2,939,719	$98,157,217
3	INCY	Incyte Corp	731,774	$82,953,900
4	CORT	Corcept Therapeutics Inc	695,532	$60,476,507
5	HALO	Halozyme Therapeutics, Inc.	322,377	$25,232,447
6	EXEL	Exelixis, Inc.	415,650	$22,615,516
7	AUPH	Aurinia Pharmaceuticals Inc.	1,231,516	$20,898,826
8	ALNY	Alnylam Pharmaceuticals, Inc.	60,986	$18,358,615

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$13,714,082	1,015,106	+7324.2%	Shares	Sole	2026-08-14
2026-03-31	$118,408	13,673	-75.7%	Shares	Sole	2026-05-15
2025-12-31	$447,068	56,235	-27.3%	Shares	Sole	2026-02-13
2023-03-31	$400,137	77,396	-64.1%	Shares	Sole	2023-05-15
2022-12-31	$1,404,962	215,485	+278.2%	Shares	Sole	2023-02-14
2021-03-31	$822,091	56,971	-24.4%	Shares	Sole	2021-05-17
2020-12-31	$1,140,465	75,328	+86.5%	Shares	Sole	2021-02-16
2020-09-30	$534,816	40,394	+101.4%	Shares	Sole	2020-11-16
2020-06-30	$251,113	20,057	—	Shares	Sole	2020-08-17
No filing history on record for this holder in this stock.